Theranos has been on quite the roller-coaster ride lately - and it hasn't been pretty. But it looks like the next attempt at reputation and credibility redemption comes in the form of an expanded Medical Advisory Board.
Bioengineers at Rice University have shown in a new study that a single finger-prick blood test really isn't that simple, probably isn't accurate.
FASENRA® (benralizumab) injection, for subcutaneous use, 30 mg is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). FASENRA provides a treatment option for HCPs to consider when managing this challenging disease.